Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nynke Boonstra

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Bjpsych Open|May 16, 2024
Evaluating changes in functioning and psychological distress in visitors of the @ease youth mental health walk-in centres - ERRATUMAnouk Boonstra, Therese A M J van Amelsvoort, Rianne M C Klaassen, et al.
Plos One|July 6, 2026
Health-related quality of life and cost-of-illness in young people seeking peer support at @ease: A Dutch burden of disease studyAnouk Boonstra, Ghislaine A P G van Mastrigt, Silvia M A A Evers, et al.
Brain Sciences|January 24, 2025
Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS)Tim van Brouwershaven, Anika Poppe, Gerdina Hendrika Maria Pijnenborg, et al.
Journal of Psychiatric Research|December 21, 2024
Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment studyMatej Djordjevic, Hannah E Jongsma, Claudia J P Simons, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speedShiral S Gangadin, Franciska de Beer, Ben Wijnen, et al.
Frontiers in Psychiatry|May 1, 2023
Self-stigma and cognitive insight in individuals at ultra-high risk for psychosisBouwina Esther Sportel, Mirjam van Enthoven, Rozanne J M van Donkersgoed, et al.
Psychological Medicine|January 2, 2026
Negative association between cognitive functioning and antipsychotic D<sub>2</sub> receptor occupancy, affinity, and dose after first episode psychosisPriscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan, et al.
Psychological Medicine|September 8, 2025
Dopamine D<sub>2/3</sub>R availability after discontinuation of antipsychotic treatment: a [<sup>11</sup>C]raclopride PET study in remitted first-episode psychosis patientsFranciska de Beer, Erik de Vries, Ben Wijnen, et al.
JAMA Psychiatry|October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical TrialIris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Pilot and Feasibility Studies|May 2, 2020
A cognitive remediation training for young adults with psychotic disorders to support their participation in education - study protocol for a pilot randomized controlled trialLana K M Otto, Jacomijn Hofstra, Michelle G Mullen, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Bjpsych Open|May 16, 2024
Evaluating changes in functioning and psychological distress in visitors of the @ease youth mental health walk-in centres - ERRATUMAnouk Boonstra, Therese A M J van Amelsvoort, Rianne M C Klaassen, et al.
Plos One|July 6, 2026
Health-related quality of life and cost-of-illness in young people seeking peer support at @ease: A Dutch burden of disease studyAnouk Boonstra, Ghislaine A P G van Mastrigt, Silvia M A A Evers, et al.
Brain Sciences|January 24, 2025
Dutch Validation of the Self-Evaluation of Negative Symptoms Scale (SNS)Tim van Brouwershaven, Anika Poppe, Gerdina Hendrika Maria Pijnenborg, et al.
Journal of Psychiatric Research|December 21, 2024
Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment studyMatej Djordjevic, Hannah E Jongsma, Claudia J P Simons, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speedShiral S Gangadin, Franciska de Beer, Ben Wijnen, et al.
Frontiers in Psychiatry|May 1, 2023
Self-stigma and cognitive insight in individuals at ultra-high risk for psychosisBouwina Esther Sportel, Mirjam van Enthoven, Rozanne J M van Donkersgoed, et al.
Psychological Medicine|January 2, 2026
Negative association between cognitive functioning and antipsychotic D<sub>2</sub> receptor occupancy, affinity, and dose after first episode psychosisPriscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan, et al.
Psychological Medicine|September 8, 2025
Dopamine D<sub>2/3</sub>R availability after discontinuation of antipsychotic treatment: a [<sup>11</sup>C]raclopride PET study in remitted first-episode psychosis patientsFranciska de Beer, Erik de Vries, Ben Wijnen, et al.
JAMA Psychiatry|October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical TrialIris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Pilot and Feasibility Studies|May 2, 2020
A cognitive remediation training for young adults with psychotic disorders to support their participation in education - study protocol for a pilot randomized controlled trialLana K M Otto, Jacomijn Hofstra, Michelle G Mullen, et al.
Pageof 7